PDCD1 and cancer: For example, combination therapy with immune checkpoint inhibitors of cytotoxic T lymphocyte-associated protein 4 (CTLA) and programmed cell death 1 (PDCD1, also known as PD1) has shown effective clinical application potential in the treatment of cancer (Liu J.-N.